-
SABCS 2023丨An Interview with Dr. Santiago Escriva-de-Romanion the Novel Zaniratamab Combinations for HR+/HER2+ mBC
Oncology Frontier: Thank you for joining us, Dr. Santiago Escriva-de-Romani. We are excited to discuss the introduction of a new track in breast cancer treatment, particularly focusing on the novel anti-HER2…
-
SABCS 2023丨Treatment Approach for Leptomeningeal Carcinomatosis in Advanced Breast Cancer Patients: Antibody-Drug Conjugate Trastuzumab Deruxtecan
Oncology Frontier: Thank you for joining us. Could you please share the key results from DEBBRAH Study? Dr. Marta Vaz Batista : Certainly. DEBBRAH is a phase 2 trial, an investigator-initiated trial, funded by METZIR…
-
Dr. Taisheng Li: A New Concept in Comprehensive Diagnosis and Treatment in the Post-ART Era of HIV/AIDS
Editor’s Note: The 15th National Conference on AIDS and Hepatitis C, hosted by the Chinese Medical Association and its Infectious Diseases Branch, took place in Guangzhou from November 10 to 12, 2023. Dr. Taisheng Li, the conference chair and a renowned figure from Peking Union Medical College Hospital, delivered a captivating presentation titled “A New…
-
Examining LLDT-8’s Potential for Suppressing Immune Activation in SIV/HIV Infection: A Transcriptomic study in Rhesus Macaques
Human Immunodeficiency Virus (HIV) infection remains a global health challenge, with chronic immune activation playing a pivotal role in disease progression. While antiretroviral therapy (ART) has significantly improved the prognosis by suppressing viral replication, persistent immune activation continues to undermine immune function. LLDT-8, an optimized analog of triptolide, has emerged as a potential immunomodulatory agent,…
-
Advancements in Predicting Patient Outcomes: A Multidimensional Approach to COVID-19 with the Omicron Variant
The COVID-19 pandemic, heightened by the emergence of the Omicron variant, has presented substantial challenges in managing patient conditions and predicting outcomes. Researchers at Peking Union Medical College Hospital sought to address this by developing a dynamic prediction model utilizing machine learning techniques. This study aimed to accurately forecast the deterioration or recovery of hospitalized…
-
Pinnacle Conversation | Advancements in the Diagnosis and Treatment of Metabolism-Related Fatty Liver Disease: Discussing New Developments, Sharing Experiences from Singapore and the United States, and Addressing Global Progress
Non-alcoholic fatty liver disease (NAFLD)/metabolic-associated fatty liver disease (MAFLD) is on the rise globally and has become the leading cause of chronic liver disease in China, posing a significant threat to public health. Establishing diagnostic models based on risk factors to assist clinical diagnosis and classification, or developing non-invasive assessment methods, is an important prerequisite…
Connecting Medical Expertise through Media
